Tilray Announces Support Of Two New Clinical Research Studies In Australia And Canada

MCRI

CANADA: Tilray, Inc., a global leader in cannabis research and production, today announced its support of two new clinical studies: a pilot study led by Murdoch Children’s Research Institute (MCRI) in Melbourne, to evaluate the feasibility and acceptability of a larger randomized placebo-controlled trial of cannabis extract as a form of treatment for reducing Severe Behavioral Problems Read the full article…

OWC Pharmaceutical To Begin Testing On Cannabinoid-Infused Psoriasis Cream

Cannabis-infused Psoriasis cream

ISRAEL: OWC Pharmaceutical Research Corp., an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, announced it has received Institutional Review Board (IRB) approval to conduct safety testing on its proprietary topical crème compound for the treatment of psoriasis and related skin conditions. The approval follows the Company’s February 1, 2017 8K filing Read the full article…